|
|
||||||||
1 Université François-Rabelais, IFR 136, Faculté de Médecine, EA 3854 Bactéries et Risque Materno-Fœtal, Tours, France
2 Laboratoire de Bactériologie et Hygiène, Hôpital Trousseau, CHU, 37044 Tours cedex, France
Correspondence
Nathalie van der Mee-Marquet
n.vandermee{at}chu-tours.fr
Received August 13, 2008
Accepted October 28, 2008
We screened 500 pregnant women who had no risk factors for Streptococcus agalactiae vaginal carriage, and isolated 39 S. agalactiae strains (8 %). The density of carriage was low in 16 cases (41 %), intermediate in 16 cases (41 %) and heavy in seven cases (18 %). Strains were mostly of serotype III (41 %), Ia (26 %) and V (18 %). Thirty-five strains had at least one of five genetic markers that have been associated with virulent phylogenetic subgroups of strains. Using PCR, nine strains (23 %) were identified as belonging to CC17. The 39 vaginal strains that were studied exhibited a substantial genetic diversity; there were 39 PFGE profiles and 13 variants defined on the basis of the five genetic markers studied. The prevalence of the studied genetic characteristics was similar for strains associated with all three classes of density of carriage. These data suggest that genetic features that are markers of S. agalactiae strains able to invade the central nervous system of neonates are not determinants for vaginal adaptation.
Abbreviations: H, heavy [carriage]; I, intermediate [carriage]; L, light [carriage]; ST-17, sequence type 17.
| INTRODUCTION |
|---|
|
|
|---|
Serotype III multilocus sequence type 17 (ST-17) strains account for most neonatal infections (Quentin et al., 1995; Lin et al., 2006; Bohnsack et al., 2008). In addition, genetic markers have been associated with virulent phylogenetic subgroups of strains. These are the insertion sequence IS1548 in the hylB gene (Granlund et al., 2001), a group II intron GBSi1 that is located downstream from the C5a-peptidase gene scpB (Rolland et al., 1999) and the presence of particular prophage DNA fragments in the S. agalactiae genome (van der Mee-Marquet et al., 2006).
Here, we report the results of screening for vaginal carriage of S. agalactiae in 500 pregnant women in France using a procedure recommended by the Agence Nationale d'Accréditation et d'Évaluation en Santé (2001). The density of carriage was evaluated by using a semi-quantitative method. Serotyping, PFGE analysis and PCR screening for ST-17 clones and five genetic markers of virulent S. agalactiae subgroups were used to assess the genetic diversity of the strains. Our findings shed some light on the link between the density of S. agalactiae vaginal carriage in pregnant women and the genetic diversity and characteristics of the strains.
| METHODS |
|---|
|
|
|---|
PCR screening for ST-17. The ST-17 clone was detected by using a real-time PCR with primers for screening of the ST-17 clone (Supplementary Table S1, available in JMM Online), which amplify the gbs2018 gene variant encoding a surface protein, that is specific for the ST-17 clone, as described by Lamy et al. (2006). The additional primer set dltR/dltRAS (Lamy et al., 2006), which amplifies the dltR regulation gene present in all S. agalactiae strains, was used as an amplification control. The PCR assay was performed on a Chromo 4 System Instrument (Bio-Rad) in a final volume of 25 µl, containing 5 µl extracted DNA, 0.5 µM each primer and 1 unit iQ SYBR green Supermix (Qiagen), including 3 mM MgCl2. Amplification involved 40 cycles of 10 s at 95 °C, 5 s at 55 °C and 10 s at 72 °C. The reaction product was then cooled to 35 °C and subjected to a post-PCR melting cycle by elevating the temperature by 0.2 °C every 10 s, up to 95 °C.
Detection of genetic markers of virulent S. agalactiae strains. The isolated strains were serotyped using PCR (Kong et al., 2002). As previously shown, strains able to invade the central nervous system of neonates frequently carry certain genetic markers at significant levels. Two of these markers are mobile genetic elements [the GBSi1 group II intron downstream from the C5a-peptidase scpB gene (Rolland et al., 1999) and IS1548 in the hylB gene, which encodes a hyaluronate lyase (Granlund et al., 2001)] and three are prophagic DNA fragments (van der Mee-Marquet et al., 2006). PCR was used to test for the presence of these genetic markers as previously described (Bidet et al., 2003; Rolland et al., 1999; van der Mee-Marquet et al., 2006) (see Supplementary Table S1 for primers).
PFGE. The genetic diversity of the isolated strains was studied by SmaI DNA macrorestriction. DNA was extracted from the isolates, digested with SmaI and then subjected to PFGE, as described previously (Rolland et al., 1999). The gels were stained with ethidium bromide and photographed with a Polaroid instant camera. The PFGE profiles were analysed with the Taxotron package (Taxolab; Institut Pasteur, Paris, France). The images were transferred to a microcomputer, and the distances migrated by each band in each lane were determined in pixel units by RestrictoScan. The size of each fragment was calculated from the distance migrated using cubic Schaffer and Sederoff method algorithms with RestrictoTyper. This software also generated a schematic representation of electrophoretic patterns and produced a distance matrix. The relationships between pulsotypes were determined by the unweighted pair group method using arithmetic means and the Adanson pulsogrouping program (dissimilarity). A dendrogram was drawn with Dendrograf.
| RESULTS |
|---|
|
|
|---|
|
Genetic diversity of the 39 S. agalactiae strains (Fig. 1
)
DNA macrorestriction of the 39 strains identified 39 different PFGE profiles. The strains clustered mostly (36 strains) in two major divisions named A (17 strains) and B (19 strains). Most division A strains were serotype III (9/17; 53 %) and division B contained numerous serotype I strains (9/19; 47 %). Eight of the nine ST-17 strains were in PFGE division A and one was in PFGE division B.
The prevalence of strains carrying the genetic markers that were tested for was significantly higher in division A than in division B; 13 of 17 (76 %) strains in division A had two or more markers, whereas these were possessed by only four of 19 (21 %) strains in division B (P<0.001). Variants V1–V8 were significantly associated with division A and variants V9–V13 with division B (P<0.001).
Density of S. agalactiae carriage and characteristics of strains
The density of vaginal carriage was H in seven cases, I in 16 cases and L in 16 cases (Table 1
). There was no significant association between the density of carriage and the strain serotype. Nevertheless, serotype III strains were mostly involved in L carriage (nine cases for 16 serotype III strains) and serotype V strains in I carriage (five cases for seven serotype V strains).
|
The density of carriage was not significantly associated with the presence or absence of the five genetic markers studied or the distribution the five major genetic variants between the strains (Table 1
). Nevertheless, 10 of the 16 GBSi1-positive strains were involved in L carriage, nine of the 16 F7-positive strains were isolated from I carriage and 10 of the 13 strains belonging to genetic variants 1 and 2 were from cases of L carriage.
| DISCUSSION |
|---|
|
|
|---|
We determined a prevalence of S. agalactiae vaginal carriage of 8 %, although this was slightly lower than values reported by others, these data are nevertheless in accordance with the findings of recent European studies (Agence Nationale d'Accréditation et d'Évaluation en Santé, 2001). These vaginal strains mostly belonged to serotypes III and Ia, and exhibited substantial genetic diversity; in fact, every strain had a different PFGE profile (39 profiles for the 39 strains) and the pattern of the presence and absence of mobile genetic elements and prophagic DNA fragments in the genome were similarly diverse (13 variants for 39 strains on the basis of five genetic elements). In accordance with their known clonality (Lamy et al., 2006), the nine ST-17-positive strains by PCR were all of serotype III and clustered into one of the two major PFGE divisions (division A). Nevertheless, these nine strains all gave different PFGE profiles (with a percentage of similarity of 35 %) and could be classified into variants on the basis of the genetic markers (n=3).
These data indicate that the vagina can be colonized by a large variety of S. agalactiae strains. Thus, the vagina appears to be a moderately effective anatomical barrier. The substantial genetic diversity of these strains suggests that the ability of S. agalactiae to colonize the vagina is predominantly a consequence of the local vaginal environment, which may or may not provide conditions for survival and growth, rather than of the nature or genetic features of the bacteria.
Several studies using selective media and semi-quantitative culture have demonstrated that both the risk of vertical transmission at the time of delivery and the risk of neonatal infections correlate with the density of vaginal carriage. Neonates born to heavily colonized women are significantly more likely to be colonized and/or infected than those born to lightly colonized women (Anthony & Okada, 1977). We evaluated the level of carriage using a method based on the density of growth observed in culture. This method was only semi-quantitative, but was nevertheless adequate to define H, I and L levels of carriage. We found that the prevalence of the genetic markers associated with strains responsible for neonatal meningitis were equally represented in the strains of these three different classes of density of carriage. Therefore, dense vaginal inocula, associated with a high risk of neonatal colonization or infection, appeared not to be related to particular strains.
Current guidelines recommend prenatal culture-based screening for S. agalactiae colonization for all pregnant women and intrapartum chemoprophylaxis by intravenous administration of antibiotics for all women who are colonized (Agence Nationale d'Accréditation et d'Évaluation en Santé, 2001; Schrag et al., 2002). This approach is more effective than the risk-based approach for preventing perinatal S. agalactiae disease but may have adverse effects. Excessive exposure to antibiotics may lead to the emergence of more resistant and/or more virulent pathogens, severe allergic reactions and, in the long term, ecological disturbance of the natural flora and even abnormal immunological development in the children. It would be beneficial to minimize intrapartum and neonatal antibiotic prophylaxis when the colonized mother delivers at term with no risk factors and/or when the colonized neonate has no symptoms. Two research avenues could be explored with this aim in mind: (i) the detection of further markers of strains in the vaginal flora associated with a high risk of invasive disease and (ii) the development of exploitable microbiological methods to quantify precisely the density of vaginal colonization at the time of the delivery.
Work to identify markers of strains associated with a high risk of invasive disease in the vaginal flora should be continued. Although several genetic markers associated with strains responsible for neonatal meningitis have been described already, there is no single marker yet described as being significantly associated with other major S. agalactiae infectious diseases (including chorioamniotitis, pneumonia and bacteraemia). In addition, our data indicate that the known genetic markers are prevalent in the vaginal S. agalactiae population, highlighting the need to improve our knowledge of this pathogen.
The development of microbiological methods to quantify precisely the density of vaginal colonization at the time of the delivery would be valuable because the attack rate for early onset disease is significantly higher in neonates born from heavily colonized women than from lightly colonized women (Anthony & Okada, 1977). In our population of pregnant women that were without risk factors, light vaginal colonization was frequent (44 %). Thus, the development of reliable and cheap tools able to quantify precisely the density of S. agalactiae carriage in pregnant women at low risk is a promising approach to limiting intrapartum chemoprophylaxis and its adverse effects. Nevertheless, epidemiological studies will have to be conducted to determine the level of the S. agalactiae carriage to be used as a cut-off and thereby optimize the risk/benefit ratio for prophylaxis.
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |